SFRP1 is a possible candidate for epigenetic therapy in non-small cell lung cancer

Title
SFRP1 is a possible candidate for epigenetic therapy in non-small cell lung cancer
Authors
Keywords
Histone Modification, Promoter Methylation, Root Mean Square Deviation, HDAC Inhibitor, NSCLC Cell Line
Journal
BMC Medical Genomics
Volume 9, Issue S1, Pages -
Publisher
Springer Nature
Online
2016-08-12
DOI
10.1186/s12920-016-0196-3

Ask authors/readers for more resources

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started